Annual CFO
-$6.04 M
-$1.97 M-48.32%
December 1, 2023
Summary
- As of February 7, 2025, BIAF annual cash flow from operations is -$6.04 million, with the most recent change of -$1.97 million (-48.32%) on December 1, 2023.
- During the last 3 years, BIAF annual CFO has fallen by -$3.83 million (-173.50%).
- BIAF annual CFO is now -194.67% below its all-time high of -$2.05 million, reached on December 31, 2021.
Performance
BIAF Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.71 M
-$176.80 K-11.54%
September 1, 2024
Summary
- As of February 7, 2025, BIAF quarterly cash flow from operations is -$1.71 million, with the most recent change of -$176.80 thousand (-11.54%) on September 1, 2024.
- Over the past year, BIAF quarterly CFO has increased by +$636.80 thousand (+27.14%).
- BIAF quarterly CFO is now -371.24% below its all-time high of -$362.70 thousand, reached on June 30, 2021.
Performance
BIAF Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$7.20 M
-$176.70 K-2.51%
September 1, 2024
Summary
- As of February 7, 2025, BIAF TTM cash flow from operations is -$7.20 million, with the most recent change of -$176.70 thousand (-2.51%) on September 1, 2024.
- Over the past year, BIAF TTM CFO has dropped by -$349.20 thousand (-5.09%).
- BIAF TTM CFO is now -1735.39% below its all-time high of -$392.50 thousand, reached on March 31, 2021.
Performance
BIAF TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BIAF Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.3% | +27.1% | -5.1% |
| 3 y3 years | -173.5% | +27.1% | -5.1% |
| 5 y5 years | -173.5% | +27.1% | -5.1% |
BIAF Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -194.7% | at low | -354.4% | +27.1% | -251.6% | at low |
| 5 y | 5-year | -194.7% | at low | -371.2% | +27.1% | -1735.4% | at low |
| alltime | all time | -194.7% | at low | -371.2% | +27.1% | -1735.4% | at low |
BioAffinity Technologies Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.71 M(+11.5%) | -$7.20 M(+2.5%) |
| Jun 2024 | - | -$1.53 M(-34.7%) | -$7.03 M(+2.5%) |
| Mar 2024 | - | -$2.35 M(+45.1%) | -$6.85 M(+13.5%) |
| Dec 2023 | -$6.04 M(+48.3%) | -$1.62 M(+5.5%) | -$6.04 M(+5.5%) |
| Sep 2023 | - | -$1.53 M(+12.7%) | -$5.72 M(-3.8%) |
| Jun 2023 | - | -$1.36 M(-11.1%) | -$5.95 M(+19.8%) |
| Mar 2023 | - | -$1.53 M(+17.6%) | -$4.97 M(+22.0%) |
| Dec 2022 | -$4.07 M | -$1.30 M(-26.1%) | -$4.07 M(+18.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$1.76 M(+368.0%) | -$3.42 M(+48.6%) |
| Jun 2022 | - | -$376.10 K(-40.7%) | -$2.30 M(+0.6%) |
| Mar 2022 | - | -$634.00 K(-2.8%) | -$2.29 M(+11.8%) |
| Dec 2021 | -$2.05 M(-7.2%) | - | - |
| Dec 2021 | - | -$652.40 K(+1.7%) | -$2.05 M(+46.7%) |
| Sep 2021 | - | -$641.30 K(+76.8%) | -$1.40 M(+84.9%) |
| Jun 2021 | - | -$362.70 K(-7.6%) | -$755.20 K(+92.4%) |
| Mar 2021 | - | -$392.50 K | -$392.50 K |
| Dec 2020 | -$2.21 M | - | - |
FAQ
- What is bioAffinity Technologies annual cash flow from operations?
- What is the all time high annual CFO for bioAffinity Technologies?
- What is bioAffinity Technologies annual CFO year-on-year change?
- What is bioAffinity Technologies quarterly cash flow from operations?
- What is the all time high quarterly CFO for bioAffinity Technologies?
- What is bioAffinity Technologies quarterly CFO year-on-year change?
- What is bioAffinity Technologies TTM cash flow from operations?
- What is the all time high TTM CFO for bioAffinity Technologies?
- What is bioAffinity Technologies TTM CFO year-on-year change?
What is bioAffinity Technologies annual cash flow from operations?
The current annual CFO of BIAF is -$6.04 M
What is the all time high annual CFO for bioAffinity Technologies?
bioAffinity Technologies all-time high annual cash flow from operations is -$2.05 M
What is bioAffinity Technologies annual CFO year-on-year change?
Over the past year, BIAF annual cash flow from operations has changed by -$1.97 M (-48.32%)
What is bioAffinity Technologies quarterly cash flow from operations?
The current quarterly CFO of BIAF is -$1.71 M
What is the all time high quarterly CFO for bioAffinity Technologies?
bioAffinity Technologies all-time high quarterly cash flow from operations is -$362.70 K
What is bioAffinity Technologies quarterly CFO year-on-year change?
Over the past year, BIAF quarterly cash flow from operations has changed by +$636.80 K (+27.14%)
What is bioAffinity Technologies TTM cash flow from operations?
The current TTM CFO of BIAF is -$7.20 M
What is the all time high TTM CFO for bioAffinity Technologies?
bioAffinity Technologies all-time high TTM cash flow from operations is -$392.50 K
What is bioAffinity Technologies TTM CFO year-on-year change?
Over the past year, BIAF TTM cash flow from operations has changed by -$349.20 K (-5.09%)